Egger, M., Smith, G.D., Stettler, C. and Diem, P. (1997) Risk of Adverse Effects of Intensified Treatment in Insulin-Dependent Diabetes Mellitus: A Meta-Analysis. Diabetic Medicine, 14, 919-928.
http://dx.doi.org/10.1002/(SICI)1096-9136(199711)14:11<919::AID-DIA456>3.0.CO;2-A

has been cited by the following article:

• TITLE: Better Glycaemic Outcome, Low Levels of Acute Severe Complications, and High Patient Satisfaction in Routine Practice in Type 1 Diabetes Treated with an Insulin Pump

  AUTHORS: H. J. Gjessing, U. L. Jørgensen, C. C. Møller, J. Pedersen, E. Grodum, K. Schousboe

  KEYWORDS: Type 1 Diabetes, CSII, Glycaemic Control, Hypoglycaemia, Ketoacidosis, Patient Satisfaction

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.4 No.4, October 20, 2014

  ABSTRACT: Treatment of patients with Type 1 diabetes with continuous subcutaneous insulin infusion (CSII) was re-introduced in Denmark in this millennium and initiated in the diabetes clinic, Fredericia Hospital, in 2005. The aim of the present study was to present yearly data of quality from 2005 to 2013 from a clinical database of patients treated with CSII in routine practice. Methods: A database was established in 2009-2010. Data from 2005 to 2009 are retrospective, data from 2009 to 2013 prospective. From 2009, patient satisfaction was measured by validated questionnaires. Results: By 31 December 2013, the database contained data from 143 active patients. HbA1C (median and range) decreased from 64 (40 - 126) mmol/mol (8.0 (5.8 - 13.7)%) (n = 104) to 60 (36 - 98) mmol/mol (7.6 (5.4 - 11.1)%) (n = 134) (p